(MENAFN- GlobeNewsWire - Nasdaq) The global needles market is projected to grow from USD 8.1 billion in 2024 to USD 14.7 billion by 2035, at a CAGR of 6.1%. This growth is driven by rising chronic ...

The "Needle Free Drug Delivery Devices Market Industry Trends and Forecasts to 2035 -- Distribution by Type of Device, Route ...

Anglo-Swedish pharma major AstraZeneca and Korean biotech Alteogen have entered into an exclusive license agreement for ...

US pharma major Merck & Co (NYSE: MRK) has shared the first results from a late-stage trial of a subcutaneous version of its ...

Enable Injections, Inc. (“Enable”), a healthcare innovation company developing and manufacturing the enFuse® wearable drug ...

The LifeSite subcutaneous access system allows immediate hemodialysis after implantation. The device consists of a silicone cannula, which is placed in a central venous location (usually via the ...

The team from Massachusetts Institute of Technology (MIT) have suggested that the technology could be useful for applications ...

Enable Injections’ enFuse Syringe Transfer System has secured CE mark approval under the European Union Medical Device ...

Argenx is a hold due to limited catalysts in 2025, a rich valuation and clinical risk around label expansion. Read more about ...

The company ended 2024 with just under $127 million in cash reserves, and nothing in its pipeline beyond the Alzheimer's ...